Biomx Inc (PHGE) Financials

$0.15

$-0.67 (-81.92%)

As on 04-Sep-2026 19:59EDT

Market cap

$4 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.33	--	--	-0.36	-0.13	--
Cost of Revenue	2.63	2.92	1.80	0.87	2.52	2.57
Gross Profit	-2.30	-2.92	-1.80	-0.87	-2.65	-2.57
Operating Expenses	20.14	29.99	37.22	26.81	27.22	35.46
Operating Profit (EBIT)	-22.44	-32.91	-39.03	-27.69	-27.22	-35.46
Other Income	--	--	--	--	--	--
Profit before Tax	-45.49	-36.19	-17.71	-26.15	-28.25	-36.16
Provision for Tax	0.00	0.01	0.01	0.02	0.07	0.07
Profit after Tax (Net Income)	-45.42	-36.20	-17.73	-26.17	-28.32	-36.23
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-36.23

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	10.87	-1.30	24.15	3.08	21.04	47.54
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.38	65.16	10.82	10.77	16.55	19.41
Current Liabilities	10.18	6.38	8.27	11.18	7.94	11.04
Total Liabilities	38.37	70.24	43.23	25.03	45.53	77.99

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	25.77	64.66	22.71	7.40	8.65	11.35
Current Assets	2.42	5.58	20.52	17.63	36.88	66.64
Total Assets	30.60	70.24	43.23	25.03	45.53	77.99
Total Debt*	3.37	1.44	9.58	15.09	19.36	20.02
Net Current Assets	--	-0.80	12.25	6.46	28.94	55.60

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-26.39	-36.98	-21.29	-29.09	-27.57
Cash Flow from Investing Activities	--	0.11	0.72	1.95	-2.11	16.17
Cash from Financing Activities	--	13.19	38.37	2.90	0.29	37.28
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.39	-0.02	-1.85	-5.69	-17.95	-24.16
Cash EPS ($)	--	-0.02	-1.66	-5.41	-16.35	-22.45
Adjusted Book Value ($)	--	--	2.52	0.67	13.33	31.70
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.02	-3.87	-4.63	-18.44	-18.39
Free Cash Flow per Share ($)	--	-0.02	-3.87	-4.64	-18.51	-20.84

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-213.78	-68.31	-89.36	-52.46	-55.34
ROE (%)	--	-316.90	-130.21	-216.99	-82.59	-69.00
ROA (%)	-121.25	-63.80	-51.94	-74.18	-45.85	-48.84
EBIT Margin (%)	-8,249.40	--	--	6,634.73	19,539.55	--
Net Margin (%)	-13,679.22	--	--	7,330.25	21,132.09	--
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	277.27	--	1.00	-1.66	--	--
EBIT Growth (%)	-118.67	-135.85	36.98	9.54	26.16	-17.19
Net Profit Growth (%)	-96.24	-104.20	32.26	7.59	21.83	-20.41
EPS Growth (%)	91.59	0.99	0.67	0.68	0.26	0.02
Book Value Growth (%)	-90.94	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-84.26	-0.39	-0.05	-0.01	-0.07
Price / Book Value	0.88	-2,342.58	0.29	0.42	0.01	0.05
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.25	-94.36	0.09	-0.06	0.58	1.21
Close Price ($)	--	1.87	13.87	53.20	35.53	304.00
High Price ($)	--	105.12	162.45	131.10	406.60	1,719.50
Low Price ($)	--	1.50	9.12	33.25	25.08	269.80
Market Cap ($ Cr)	3.80	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-1.10	0.40	4.90	0.92	0.42
Short term debt to equity ratio	0.29	-1.10	0.05	2.09	0.24	0.02
Current Ratio	0.24	0.87	2.48	1.58	4.65	6.03
Quick Ratio	0.24	--	2.60	--	4.60	6.02
Interest Coverage	-54.33	-35.78	-5.36	-9.85	-12.65	-50.73

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	98.49	--	--	-160.78	-423.13	--
Asset Turnover	0.01	--	--	-0.01	0.00	--
Receivable days	--	--	--	-583.68	-1,982.98	--
Inventory Days	--	-119.75	-194.07	165.64	36.45	15.38
Payable days	--	312.63	330.51	461.49	261.98	364.18
Cash Conversion Cycle	--	--	--	-879.53	-2,208.51	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.